CTRI/2024/01/061801
Not yet recruiting
未知
A prospective, interventional, and multi-center study to characterize the efficacy and performance of the 100% Silicone Foley Balloon Catheter 2-way, 100% Silicone Foley Balloon Catheter – BH model 2-way, and 100% Silicone Foley Balloon Catheter – Star/ Ribbed model 2-way - nil
Sterimed Group0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: N00-N99- Diseases of the genitourinary system
- Sponsor
- Sterimed Group
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.All subjects who undergo urinary catheterization indicated for long term catheterization of minimum of 30 days
- •2\.Both Male and Female patients will be enrolled
- •3\.All patients who are willing to provide informed consent for participation in the study
Exclusion Criteria
- •1\.Subjects not suitable for intervention with silicone Foley catheter
- •2\.All subjects who are not willing to provide informed consent for participation in the study
- •3\.Pediatric population
- •4\.Neurogenic bladder condition subjects
- •5\.Immobilized subjects
- •6\.Subjects having urethral strictures
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 4
A multi-hospital approach that depicts the routine practice of doctors treating patients with type 2 diabetes with Novomix 30, which will evaluate willingness and ability to pay in a real world population.CTRI/2017/10/010218ovo Nordisk India Private Ltd
Completed
Not Applicable
A non-interventional, prospective, multicenter study to describe patient preference and real-world outcomes of Diroximel Fumarate for the treatment of relapsing remitting multiple sclerosis in daily clinical practiceG35.1DRKS00029567Biogen GmbH118
Completed
Phase 4
Clinical Study of fixed dose combination of FLUCOLD TABLET in the Treatment of common cold and flu in adult populatioHealth Condition 1: J00- Acute nasopharyngitis [common cold]CTRI/2020/07/026402Wallace Pharmaceuticals Pvt Ltd199
Completed
Phase 4
Clinical Study of fixed dose combination of FLUCOLD DROPS in the Treatment of common cold and flu syndrome in infants and childreHealth Condition 1: J00- Acute nasopharyngitis [common cold]CTRI/2020/06/026109Wallace Pharmaceuticals Pvt Ltd220
Completed
Phase 4
Clinical Study of fixed dose combination of FLUCOLD SYRUP in the Treatment of common cold and flu symptoms in childreCTRI/2020/06/026248Wallace Pharmaceuticals Pvt Ltd204